| 摘要 |
Disclosed is a use of (a) apoaequorin; and (b) an acceptable carrier, in the manufacture of a medicament for treating a symptom or disorder associated with calcium imbalance for example a disorder associated with sleep, energy, mood, pain, or memory or is related to neuronal excitability, muscle contraction, membrane permeability, cell division, hormone secretion, bone mineralization, or cell death following ischemia.
|
